NCT02068053View on ClinicalTrials.gov

Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Immunosuppression For Disease
Interventions
DRUG

[14C] BMS-986020

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY